1Shinichi Tsutsui,Shinji Ohno,Shigeru Murakami,Yoichi Hachitanda,Shinya Oda. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer[J] 2002,Breast Cancer Research and Treatment(1):67～75
2Friederike C. von Lintig,Anna D. Dreilinger,Nissi M. Varki,Anne M. Wallace,Darren E. Casteel,Gerry R. Boss. Ras activation in human breast cancer[J] 2000,Breast Cancer Research and Treatment(1):51～62
3Carol A. Faaland,Sreedevi Adhikarakunnathu,Thresia Thomas,T.J. Thomas. Mechanism of action of a tyrphostin, 3,4-dihydroxy-α-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex[J] 1997,Breast Cancer Research and Treatment(1):47～56
同被引文献2
1Lipton A. Ali S.M,Leitzel K. et al. Elevated serum her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin 0ncol,2002,20(6): 1467- 1472.
